Skip to content
- Philip Morris sells asthma inhaler company amid ‘unwarranted opposition’ to its goalsNPR
- Philip Morris sells Vectura for $198M after health care reform backlashReuters
- Philip Morris loses $220 million on sale of inhalation medicines unitThe Wall Street Journal
- Marlboro Manufacturer Sells Group of Asthma Inhalers at Discount After Adverse Health ReactionsFinancial Times
- Molex, a parent company of Phillips Medisize, announces agreement to acquire Vectura Group Limited, expanding its inhaled drug delivery capabilitiesBusiness news